D, B., V, P., E, B., B, D., & WG, M. (2025). Biological definitions of synucleinopathies should be anchored in clinical trajectories and encompass the complex biology of the disease. Journal of Parkinson's disease, 15(5), 944. https://doi.org/10.1177/1877718X241313443
Chicago Style (17th ed.) CitationD, Bendetowicz, Planche V, Bezard E, Dehay B, and Meissner WG. "Biological Definitions of Synucleinopathies Should Be Anchored in Clinical Trajectories and Encompass the Complex Biology of the Disease." Journal of Parkinson's Disease 15, no. 5 (2025): 944. https://doi.org/10.1177/1877718X241313443.
MLA (9th ed.) CitationD, Bendetowicz, et al. "Biological Definitions of Synucleinopathies Should Be Anchored in Clinical Trajectories and Encompass the Complex Biology of the Disease." Journal of Parkinson's Disease, vol. 15, no. 5, 2025, p. 944, https://doi.org/10.1177/1877718X241313443.
